Accueil   Diary - News   All news ENYO Pharma strengthens its management team to support its strategy of international growth

ENYO Pharma strengthens its management team to support its strategy of international growth

logo-hdLyon, 07 November 2016. ENYO Pharma, a biopharmaceutical company currently focused on developing treatments for viral infections, has today announced that it is strengthening its management team with the appointment of four highly-qualified experts, all of whom are experts in drug development.

 


Jacky Vonderscher, Chief Executive Officer of ENYO Pharma commented, "We are delighted to welcome these four personalities whose solid experience and established skill sets will be crucial in supporting our development. These four leading experts, will contribute to developing our Corporate structure and help to accelerate the development of our flagship EYP001 project, an FXR agonist for the treatment of the Hepatitis B virus. In addition, they will foster the development of new therapeutic approaches to other viruses and other significant clinical areas".

 

Read the press release

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree